News

Learn more about our latest achievements, product updates, and our involvement in research projects

Monsenso signs agreement to support global pharmaceutical across Europe

Monsenso signs agreement to support global pharmaceutical across Europe

Following a year-long collaboration, Monsenso signs a three-year +10 mio DKK agreement with a global pharmaceutical company. Monsenso’s mobile health solution will be used for real-world data collection across two studies in connection with the launch of a new drug for depression treatment. The studies are expected to start in the first half of 2021 and will run over a three-year period, covering up to 2250 patients and 120 clinicians across Belgium, the Netherlands, the United Kingdom, Switzerland, Italy, Spain, Denmark, Sweden and France.

Monsenso is ISO 13485 certified

Monsenso is ISO 13485 certified

As a technology leader in mobile health (mHealth) solutions for mental health, Monsenso is ISO 13485 certified. ISO 13485 is the gold standard for medical device companies to ensure the quality, safety and efficacy of products in the medical device field

Monsenso receives ISO 27001 re-certification

Monsenso receives ISO 27001 re-certification

Copenhagen, Denmark – 23 July 2020. Monsenso, a technology leader in mobile health (mHealth) solutions for mental health, has received the ISO 27001 re-certification. This is the international standard that describes best practices for an information security management system (ISMS).